Adnan Alseidi, M.D., Ed.M
- Professor of Surgery
- Division of Surgical Oncology
- Vice Chair for Education,
- Department of Surgery
Contact Information
Biography
Adnan Alseidi, MD, EdM, is Professor of Clinical Surgery and Vice Chair for Education in the Department of Surgery at UCSF. Dr. Alseidi has extensive experience with minimally invasive and open hepatobiliary, pancreatic and endocrine surgeries. Additionally, he is interested in expanding surgical therapies for patients with locally advanced pancreas cancer, splenic preservation techniques, and immunology studies.
Dr. Alseidi holds many national and international position to include being the current president of the Association of Surgical Education, the Present-elect for the fellowship council, the Chair for training and education for HPB surgery for the Americas Hepato-Pancreato-Biliary Association and the Society of American Gastrointestinal and Endoscopic Surgeons.
A graduate of UC, Santa Barbara, and Pennsylvania State University Medical School,Dr. Alseidi completed his general surgery residency at the University of Illinois at Chicago. Following graduation from residency, he served as a surgeon in the US Navy and as a Co-director of the Surgery Department at the US Naval Hospital in Okinawa, Japan. Dr. Alseidi completed an HPB and advanced GI fellowship at Washington University in St. Louis, MO and earned a master's degree in surgical education at Southern Illinois University/University of Illinois-UC.
From 2011– March 2020, Dr. Alseidi was an attending HPB and endocrine surgeon at Virginia Mason Medical Center in Seattle, WA where he held the roles of Director of the HPB Clinical Fellowship, Surgical Simulation Training, and Associate Program Director of the general surgery residency.
Education & Training
Institution
Degree
Dept or School
End Date
Awards & Honors
Award
Confired By
Date
Fellowships
- 2011 Clinical Fellowship, Hepato-Pancreato-Biliary & Advanced GI Surgery, Washington University at Saint Louis, St. Louis, MO
Clinical Expertise
- Adrenal cancer
- Adrenal masses
- Bile Duct Cancer (Cholangiocarcinoma)
- Bile Duct Injuries
- Bile Duct Strictures
- Bridging Therapies to Downstage HCC in Setting of Liver Transplantation
- Choledochal Cysts
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- Gastrointestinal Stromal Tumor (GIST)
- Hyperparathyroidism
- Liver Cancer (Hepatocellular Carcinoma)
- Liver Cysts
- Liver Metastases
- Minimally invasive and open hepatobiliary surgery
- Minimally invasive and open pancreas surgery
- Minimally Invasive Liver & Pancreas Surgery
- Pancreatic Cancer
- Pancreatic Cysts
- Pancreatic Neuroendocrine (Islet Cell) Tumors
- Portal Hypertension
- Stomach (Gastric) Cancer
- Thyroid cancer
- Thyroid goiters
- Thyroid nodules
Research Overview
Dr. Alseidi's research interests include global assessment of psychomotor skills, linkages between surgical education and patient outcomes, complex MIS training, and surgical performance improvement.
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 157
Data provided by UCSF Profiles, powered by CTSI
- Vreeland TJ, Collings AT, Ozair A, Adams AM, Dirks R, Kushner BS, Sucandy I, Morrell D, Whiteside J, Ansari MT, Cloyd J, Cleary SP, Ceppa E, Abou-Setta AM, Alseidi A, Awad Z, Ayloo S, Buell J, Orthopoulos G, Richardson W, Sbayi S, Wakabayashi G, Asbun H, Slater BJ, Pryor AD, Jeyarajah DR. SAGES/AHPBA guidelines for the use of minimally invasive surgery for the surgical treatment of colorectal liver metastases (CRLM). Surg Endosc. 2023 Feb 21. View in PubMed
- Carpenter EL, Flinn AN, Schechtman DW, Adams AM, Clifton GT, Krell RW, Alseidi AA, Vreeland TJ, Schaffner TJ. Iatrogenic Inferior Vena Cava Injury in the Reoperative Foregut: a Technique for Minimally Invasive Repair. Obes Surg. 2023 Jan 30. View in PubMed
- de Muynck LDAN, White KP, Alseidi A, Bannone E, Boni L, Bouvet M, Falconi M, Fuchs HF, Ghadimi M, Gockel I, Hackert T, Ishizawa T, Kang CM, Kokudo N, Nickel F, Partelli S, Rangelova E, Swijnenburg RJ, Dip F, Rosenthal RJ, Vahrmeijer AL, Mieog JSD. Consensus Statement on the Use of Near-Infrared Fluorescence Imaging during Pancreatic Cancer Surgery Based on a Delphi Study: Surgeons' Perspectives on Current Use and Future Recommendations. Cancers (Basel). 2023 Jan 20; 15(3). View in PubMed
- Lin JJ, Conroy PC, Romero-Hernandez F, Yilma M, Feng J, Hirose K, Nakakura E, Maker AV, Corvera C, Kirkwood K, Alseidi A, Adam MA. Hypertension Requiring Medication Use: a Silent Predictor of Poor Outcomes After Pancreaticoduodenectomy. J Gastrointest Surg. 2023 02; 27(2):328-336. View in PubMed
- Berardi G, Ratti F, Sposito C, Nebbia M, D'Souza DM, Pascual F, Dogeas E, Tohme S, D'Amico FE, Alessandris R, Simonelli I, Del Basso C, Russolillo N, Moro A, Fiorentini G, Serenari M, Rotellar F, Zimmitti G, Famularo S, Ivanics T, Hoffman D, Onkendi E, Essaji Y, Lopez Ben S, Caula C, Rompianesi G, Chopra A, Abu Hilal M, Torzilli G, Sapisochin G, Corvera C, Alseidi A, Helton S, Troisi RI, Simo K, Conrad C, Cescon M, Cleary S, Kwon CHD, Ferrero A, Ettorre GM, Cillo U, Geller D, Cherqui D, Serrano PE, Ferrone C, Mazzaferro V, Aldrighetti L, Kingham TP. Model to predict major complications following liver resection for HCC in patients with metabolic syndrome. Hepatology. 2023 Jan 03. View in PubMed
- View All Publications
Videos
Data provided by UCSF Profiles, powered by CTSI
- Leadership and Advocacy
- Young Fellows at ACS
- Spleen preservation with Distal Pancreas resection
- Minimally invasive distal pancreatectomy: To preserve or not preserve the spleen
- MIS training for practicing HPB surgeons & fellows
- The Evolving Role of Chemoradiation +/- Local Excision for Liver Cancer
- AHPBA/ILLS: Laparoscopic Liver Resection
- Spleen Preserving Left Sided Pancreatectomy - Take 1
In the News
- UCSF Department of Surgery - August 10, 2022Congratulations to Dr. Adnan Alesidi who has been selected as a new member of The Haile T. Debas Academy of Medical Educators. He will be inducted into the distinguished Academy on September 21, 2022 at the Sandler Neurosciences Center Auditorium.
